Brief: Chordate Says American Headache Society Accepts Presentation Of Pm007 Study Results
April 13 (Reuters) - Chordate Medical Holding publ AB
CMHM.ST :
* CHORDATE ANNOUNCES THAT THE AMERICAN HEADACHE SOCIETY HAS
ACCEPTED A PRESENTATION OF THE FINAL RESULTS OF THE PM007 STUDY
AT THE AHS-CONGRESS IN JUNE 2023
* RESULTS CONFIRM ABSTRACT WITH SUBGROUP RESULTS FROM GERMAN
PART
OF PM007 PRESENTED AT MIGRAINE TRUST INTERNATIONAL SYMPOSIUM
Source text for Eikon: ID:nMFN7SHf1d
Further company coverage: CMHM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln